Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. 4 Exercise or conversion VP, Controller and PAO acquired 2,448 shares (option exercise)
  2. 4 Open-market sale Director sold 6,000 shares at $49.69 ($298,140)
  3. 4 Open-market sale Director sold 6,000 shares at $55.67 ($334,020)
  4. 4 Exercise or conversion CFO & Executive Vice President acquired 12,000 shares (option exercise)
  5. 4 Open-market sale Director sold 19,550 shares at an average $72.49 ($1,417,098)
  6. 3/A Insider 3/A
  7. 4/A Open-market sale EVP and General Counsel sold 5,000 shares at $78.53 ($392,650)
  8. 4 Grant or award Chief Operating Officer acquired 15,000 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale CFO & Executive Vice President sold 6,700 shares at $90.07 ($603,469)
  11. 4 Open-market sale EVP and General Counsel sold 5,000 shares at $78.53 ($392,650)
  12. 4 Open-market sale Director sold 3,750 shares at $76.66 ($287,475)
  13. 4 Shares withheld for taxes Pinion John Richard gave up 649 shares (to pay taxes)
  14. 4 Open-market sale EVP and General Counsel sold 1,226 shares at $82.77 ($101,476)
  15. 4 Shares withheld for taxes EVP and General Counsel gave up 649 shares (to pay taxes)
  16. 4 Grant or award Director acquired 3,000 shares (grant or award)
  17. 4 Grant or award Director acquired 3,000 shares (grant or award)
  18. 4 Grant or award Director acquired 3,000 shares (grant or award)
  19. 4 Grant or award Director acquired 3,000 shares (grant or award)
  20. 4 Grant or award Director acquired 3,000 shares (grant or award)

Page 20 of 32 · 627 filings